| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
109.12(B) |
| Last
Volume: |
5,365,633 |
Avg
Vol: |
8,385,378 |
| 52
Week Range: |
$48.64 - $77.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
503,645 |
1,002,990 |
2,126,174 |
| Total Sell Value |
$22,679,618 |
$34,760,114 |
$61,125,774 |
$111,248,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
26 |
44 |
80 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nicholas Peter M |
Director |
– • – |
2009-09-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(200,000) |
13,886,934 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-09-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(200,000) |
14,086,934 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-09-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(200,000) |
14,286,934 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-09-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(196,066) |
14,486,934 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-09-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(196,070) |
14,683,000 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2009-08-20 |
4 |
AS |
$11.20 |
$130,682 |
D/D |
(11,668) |
29,385 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2009-08-20 |
4 |
OE |
$6.13 |
$71,525 |
D/D |
11,668 |
41,053 |
|
- |
|
| Bartlett Katharine T |
Director |
– • – |
2009-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,343 |
11,343 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-07-29 |
4 |
D |
$10.94 |
$20,863 |
D/D |
(1,907) |
16,395 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
18,302 |
|
- |
|
| Colen Fred |
President, CRM |
• – – |
2009-07-29 |
4 |
D |
$10.94 |
$16,399 |
D/D |
(1,499) |
49,973 |
|
- |
|
| Colen Fred |
President, CRM |
• – – |
2009-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,584 |
51,472 |
|
- |
|
| Gilbert James |
EVP |
• – – |
2009-07-24 |
4 |
D |
$10.57 |
$16,838 |
D/D |
(1,593) |
62,916 |
|
- |
|
| Gilbert James |
EVP |
• – – |
2009-07-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,017 |
64,509 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2009-07-24 |
4 |
D |
$10.57 |
$29,501 |
D/D |
(2,791) |
55,204 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2009-07-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,046 |
57,995 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-07-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(122,457) |
11,152,746 |
|
- |
|
| Elliott John Raymond |
President and CEOOfficer |
• • – |
2009-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,264 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-07-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(124,862) |
11,275,203 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2009-07-10 |
4 |
D |
$9.63 |
$50,972 |
D/D |
(5,293) |
51,756 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2009-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,668 |
57,049 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-07-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(142,070) |
11,400,065 |
|
- |
|
| Paul Donovan |
SVP, Corporate Comm |
• – – |
2009-07-01 |
4 |
D |
$10.11 |
$25,679 |
D/D |
(2,540) |
26,002 |
|
- |
|
| Paul Donovan |
SVP, Corporate Comm |
• – – |
2009-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
28,542 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2009-07-01 |
4 |
D |
$10.11 |
$13,810 |
D/D |
(1,366) |
29,385 |
|
- |
|
1824 Records found
|
|
Page 50 of 73 |
|
|
0.12 (0.16%) 
